Diabetes Educ:对低血糖的恐惧会影响1型糖尿病年轻成人患者的生活质量

2018-12-10 国际糖尿病编辑部 国际糖尿病

根据近期Diabetes Educator上发表的一项研究,对于1型糖尿病年轻成人患者,对低血糖和其他并发症的恐惧以及低自我效能可降低其生活质量。

根据近期Diabetes Educator上发表的一项研究,对于1型糖尿病年轻成人患者,对低血糖和其他并发症的恐惧以及低自我效能可降低其生活质量。

超过1/2的1型糖尿病患者在21岁之前被确诊,在生命早期确定生活质量的关键因素可以帮助糖尿病患者在今后保持更好的生活质量。美国伊利诺伊大学护理学院在180例糖尿病病程超过1年的18~35岁糖尿病患者(82.8%为女性,平均年龄27.35岁)中进行了一项横断面、探索性研究。所有受试者均在糖尿病学组(如美国糖尿病协会)的帮助下在线招募,并完成糖尿病相关因素评估的调查,这些糖尿病相关因素包括:生活质量、对低血糖的恐惧、对并发症的恐惧、糖尿病行为、自我管理和糖尿病管理知识。

研究人员发现,生活质量与对低血糖和其他并发症的恐惧呈负相关,生活质量与自我效能呈正相关(所有P值<0.001)。多元线性回归分析显示,对低血糖的恐惧、对其他并发症的恐惧和自我报告的效能均为生活质量最重要的因素。

对于很多1型糖尿病年轻成人患者,不愉快的低血糖经历和不可预知的低血糖负面后果会导致他们对低血糖的恐惧,使部分患者反应过度,从而采取妥协的代谢控制策略。

此外,研究还显示,使用胰岛素泵的受试者在自我报告的效能、生活质量和自我管理方面的得分都高于未使用胰岛素泵的患者。

研究认为,糖尿病管理的目标不仅是维持正常的血糖水平,还应实现高质量的生活。应强调对1型糖尿病患者的支持,并为患者找到最佳管理方案,同时,需减少患者对低血糖的担忧。

原始出处:
Denise A. Kent, et al. Factors That Affect Quality of Life in Young Adults With Type 1 Diabetes. Diabetes Educator. October 20, 2018 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1760932, encodeId=32561e6093234, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Tue Dec 11 07:47:00 CST 2018, time=2018-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638901, encodeId=91a3163890195, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue May 14 10:47:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1902183, encodeId=c0be19021838a, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sun Feb 03 13:47:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042105, encodeId=f3a3104210522, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Tue Dec 11 01:47:00 CST 2018, time=2018-12-11, status=1, ipAttribution=)]
    2018-12-11 hb2008ye
  2. [GetPortalCommentsPageByObjectIdResponse(id=1760932, encodeId=32561e6093234, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Tue Dec 11 07:47:00 CST 2018, time=2018-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638901, encodeId=91a3163890195, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue May 14 10:47:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1902183, encodeId=c0be19021838a, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sun Feb 03 13:47:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042105, encodeId=f3a3104210522, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Tue Dec 11 01:47:00 CST 2018, time=2018-12-11, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1760932, encodeId=32561e6093234, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Tue Dec 11 07:47:00 CST 2018, time=2018-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638901, encodeId=91a3163890195, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue May 14 10:47:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1902183, encodeId=c0be19021838a, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sun Feb 03 13:47:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042105, encodeId=f3a3104210522, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Tue Dec 11 01:47:00 CST 2018, time=2018-12-11, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1760932, encodeId=32561e6093234, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Tue Dec 11 07:47:00 CST 2018, time=2018-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638901, encodeId=91a3163890195, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue May 14 10:47:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1902183, encodeId=c0be19021838a, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sun Feb 03 13:47:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042105, encodeId=f3a3104210522, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Tue Dec 11 01:47:00 CST 2018, time=2018-12-11, status=1, ipAttribution=)]
    2018-12-11 misszhang

    谢谢MedSci提供最新的资讯

    0

相关资讯

Diabetic Med:2型糖尿病间歇性禁食和低血糖风险?

近日,国际杂志 《Diabetic Med》上在线发表一项关于2型糖尿病间歇性禁食和低血糖风险:一项随机对照试验的研究。以确定2型非糖尿病患者动态2天的极低热量饮食低血糖症的风险是否比非动态2天低热量饮食更高。 这是一项关于成人间歇性禁食的非盲法随机平行组介入试验。参与者的BMI为30-45kg /m 2,用二甲双胍和/或降血糖药物治疗2型糖尿病和HbA 1c浓度为50-86mmol/mo

Diabetic Med:1型糖尿病患儿父母对低血糖的意识和恐惧

近日,国际杂志 《Diabetic Med》上在线发表一项关于1型糖尿病患儿父母对低血糖的警觉和意识的荷兰MILES青年糖尿病结果的研究结果。研究目的是确定患有1型糖尿病的儿童(4-18岁)的父母对低血糖的恐惧的社会人口学和临床相关性,并调查父母对低血糖,意识和意识养育的恐惧之间的关系。从荷兰MILES青年糖尿病横断面数据集截取社会人口统计学,自我报告的临床和心理学数据。调查问卷包括低血糖恐惧调查

Diabetes Obes Metab:低血糖风险较低降糖药,MACE风险降低与糖化血红蛋白相关

2018年9月,发表于《Diabetes Obes Metab》上的一项随机对照试验的Meta分析,考察了具有较低低血糖风险的糖尿病药物对心血管结局的影响。

糖尿病人意识不清,别只想着低血糖!丨经典病例

某男性患者,67岁。既往有糖尿病史20余年,长期口服二甲双胍、阿卡波糖等药物治疗,血糖控制尚可。1周前,患者受凉后出现腹泻、水样便,伴恶心、纳差,1天前家人发现患者言行反常,遂来急诊。

药师说药:警惕这些药物与降糖药合用会导致低血糖

糖尿病的患者多为中老年人,常常合并有其他的慢性疾病,如高血压、高血脂、高尿酸血症等。因此,常常除了服用降糖药物外,还会合用其它的药物。而随着联合用药的种类和数量增多,药物不良的相互作用发生机会增大。一些药物可以与降糖药物发生相互作用,增强降糖药物的药效,导致低血糖。磺脲类药物是最常用的口服降糖药物之一,这类药物可以作用于胰腺的β细胞,促进胰岛素的释放,从而使血糖降低。

EASD2018丨低血糖增加伴有痴呆症的老年糖尿病患的死亡风险

近期一项荟萃分析显示,低血糖可能与死亡率、心血管事件、跌倒及骨折风险增加具有相关性。但是,其所纳入的研究均未涉及特定患者群尤其是低血糖风险特别高的人群如痴呆症与糖尿病并存者的严重后果。